The extent and pattern of organ damage in small vessel vasculitis measured by the Vasculitis Damage Index (VDI)

References

• Jennette J. C., Falk R. J., Andrassy K., Bacon P. A., Churg J., Gross W. L., et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187–92
   PubMed Web of Science ®Google Scholar
• Fauci A. S., Haynes B. F., Katz P., Wolff S. M. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983; 98: 76–85
   PubMed Web of Science ®Google Scholar
• Hoffman G. S., Kerr G. S., Leavitt R. Y., Hallahan C. W., Lebovics R. S., Travis W. D., et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116: 488–98
   PubMed Web of Science ®Google Scholar
• Knight A., Ekbom A., Brandt L., Askling J. Increasing incidence of Wegener's granulomatosis in Sweden, 1975–2001. J Rheumatol 2006; 33: 2060–3
   PubMed Web of Science ®Google Scholar
• Mohammad A. J., Jacobsson L. T., Mahr A. D., Sturfelt G., Segelmark M. Prevalence of Wegener's granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg–Strauss syndrome within a defined population in southern Sweden. Rheumatology (Oxford) 2007; 46: 1329–37
   PubMed Web of Science ®Google Scholar
• Koldingsnes W., Nossent H. Predictors of survival and organ damage in Wegener's granulomatosis. Rheumatology (Oxford) 2002; 41: 572–81
   PubMed Web of Science ®Google Scholar
• Exley A. R., Bacon P. A., Luqmani R. A., Kitas G. D., Gordon C., Savage C. O., et al. Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum 1997; 40: 371–80
   PubMed Web of Science ®Google Scholar
• Statistics Sweden. Population in the whole country, counties and municipalities on December 31, 2002., Available from: www.scb.se
   Google Scholar
• Watts R., Lane S., Hanslik T., Hauser T., Hellmich B., Koldingsnes W., et al. Development and validation of a consensus methodology for the classification of the ANCA‐associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 2007; 66: 222–7
   PubMed Web of Science ®Google Scholar
• Leavitt R. Y., Fauci A. S., Bloch D. A., Michel B. A., Hunder G. G., Arend W. P., et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990; 33: 1101–7
   PubMed Web of Science ®Google Scholar
• Lightfoot R. W., Jr, Michel B. A., Bloch D. A., Hunder G. G., Zvaifler N. J., McShane D. J., et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 1990; 33: 1088–93
   PubMed Web of Science ®Google Scholar
• Masi A. T., Hunder G. G., Lie J. T., Michel B. A., Bloch D. A., Arend W. P., et al. The American College of Rheumatology 1990 criteria for the classification of Churg–Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990; 33: 1094–100
   PubMed Web of Science ®Google Scholar
• Levey A. S., Bosch J. P., Lewis J. B., Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461–70
   PubMed Web of Science ®Google Scholar
• Exley A. R., Bacon P. A., Luqmani R. A., Kitas G. D., Carruthers D. M., Moots R. Examination of disease severity in systemic vasculitis from the novel perspective of damage using the vasculitis damage index (VDI). Br J Rheumatol 1998; 37: 57–63
   PubMedGoogle Scholar
• Seo P., Min Y. I., Holbrook J. T., Hoffman G. S., Merkel P. A., Spiera R., et al. Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET). Arthritis Rheum 2005; 52: 2168–78
   PubMed Web of Science ®Google Scholar
• Mahr A., Girard T., Agher R., Guillevin L. Analysis of factors predictive of survival based on 49 patients with systemic Wegener's granulomatosis and prospective follow‐up. Rheumatology (Oxford) 2001; 40: 492–8
   PubMed Web of Science ®Google Scholar
• Luqmani R. A., Bacon P. A., Beaman M., Scott D. G., Emery P., Lee S. J., et al. Classical versus non‐renal Wegener's granulomatosis. Q J Med 1994; 87: 161–7
   PubMedGoogle Scholar
• Lane S. E., Watts R. A., Shepstone L., Scott D. G. Primary systemic vasculitis: clinical features and mortality. Q J Med 2005; 98: 97–111
   Google Scholar
• Takala J. H., Kautiainen H., Malmberg H., Leirisalo‐Repo M. Wegener's granulomatosis in Finland in 1981–2000: clinical presentation and diagnostic delay. Scand J Rheumatol 2008; 29: 1–4
   Google Scholar
• de Groot K., Schmidt D. K., Arlt A. C., Gross W. L., Reinhold‐Keller E. Standardized neurologic evaluations of 128 patients with Wegener granulomatosis. Arch Neurol 2001; 58: 1215–21
   PubMedGoogle Scholar
• Guillevin L., Lhote F., Gayraud M., Cohen P., Jarrousse B., Lortholary O., et al. Prognostic factors in polyarteritis nodosa and Churg–Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore) 1996; 75: 17–28
   PubMed Web of Science ®Google Scholar
• Abu‐Shakra M., Smythe H., Lewtas J., Badley E., Weber D., Keystone E. Outcome of polyarteritis nodosa and Churg–Strauss syndrome. An analysis of twenty‐five patients. Arthritis Rheum 1994; 37: 1798–803
   PubMed Web of Science ®Google Scholar